Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients

ClinicalTrials.gov ID: NCT01301157

Public ClinicalTrials.gov record NCT01301157. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 11:30 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is to evaluate the efficacy and safety of M518101 and the dose relationship among two doses of M518101 and placebo in male and female plaque psoriasis patients.

Study identification

NCT ID
NCT01301157
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Maruho Co., Ltd.
Industry
Enrollment
294 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2011
Primary completion
Dec 31, 2011
Completion
Not listed
Last update posted
Nov 4, 2015

Started 2011

United States locations

U.S. sites
32
U.S. states
20
U.S. cities
31
Facility City State ZIP Site status
University of Alabama (UAB) Dermatology Birmingham Alabama 35233
Coastal Carolina Research Mobile Alabama 36608
Sierra Medical Research Fresno California 93710
Therapeutics Clinical Research San Diego California 92123
Clinical Science Institute Santa Monica California 90404
Visions Clinical Research Boynton Beach Florida 33472
Ameriderm Research Jacsonville Florida 32216
Ameriderm Research Ormond Beach Florida 32174
Atlanta Dermatology, Vein & Research Ctr Alpharetta Georgia 30022
NorthShore University HealthSystem Skokie Illinois 60077
Dawes Fretzin Clinical Research Group, LLC Indianapolis Indiana 46256
The Southbend Clinic, LLC South Bend Indiana 46617
Derm Research Louisville Kentucky 40217
Medical Development Centers, LLC Baton Rouge Louisiana 70808
Medical Development Centers, LLC Opelousas Louisiana 70570
Hamzavi Dermatology Fort Gratiot Michigan 48059
Central Dermatology St Louis Missouri 63117
Washington University, Dermatology Clinical Trials Unit St Louis Missouri 63141
Dartmouth-Hitchcock Medical Center, Section of Dermatology Lebanon New Hampshire 03756
Skin Search of Rochester, Inc. Rochester New York 14623
DermResearchCenter of New York, Inc Stony Brook New York 11790
Dermatology Consulting Services High Point North Carolina 27262
Wilmington Dermatology Center Wilmington North Carolina 28403
Radiant Research Columbus Ohio 43212
OUHSC-Dermatology Oklahoma City Oklahoma 73104
Baker Allergy, Asthma and Dermatology Research Center, LLC Lake Oswego Oregon 97035
Palmetto Clinical Trial Services, LLC Greenville South Carolina 29607
Arlington Research Center, Inc Arlington Texas 76011
Center for Clinical Studies, Texas Medical Center Houston Texas 77030
Dermatology Clinical Research Center San Antonio Texas 78229
Virginia Clinical Research Inc. Norfolk Virginia 23507
Dermatology Associates Seattle Washington 98101

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01301157, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 4, 2015 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01301157 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →